« Previous
Next »
Journal of Neuroimmunology
Volume 221, Issue 1
, Pages 115-120
, 15 April 2010
IFN-β reverses the lipopolysaccharide-induced proteome modifications in treated astrocytes
References
- . Interferon beta promotes survival in primary astrocytes through phosphatidylinositol 3-kinase. J. Neuroimmunol. 2003;139:155–159
- . Mechanisms of interferon-β-induced survival in fetal and neonatal primary astrocytes. Neuroimmunomodulation. 2007;14:39–45
- . Interferon-β protects astrocytes against tumour necrosis factor-induced apoptosis via activation of p38 mitogen-activated protein kinase. Exp. Cell Res. 2008;314:2231–2237
- . Interferon-beta impairs induction of HLA-DR antigen expression in cultured adult human astrocytes. J. Neuroimmunol. 1989;23:45–53
- . Bacterial lipopolysaccharide induces cytoskeletal rearrangement in small intestinal lamina propria fibroblasts: actin assembly is essential for lipopolysaccharide signalling. Biochim. Biophys. Acta. 2000;1500:125–136
- . PBMCs protein expression profile in relapsing IFN-treated multiple sclerosis: a pilot study on relation to clinical findings and brain atrophy. J. Neuroimmunol. 2009;210:80–86
- . Immune function of astrocytes. Glia. 2001;36:180–190
- . The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 2008;118:1680–1690
- . Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell line. J. Neuroimmunol. 1998;82:133–139(7)
- . Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis. Mult. Scler. 2007;13:459–470
- . Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS. Neurology. 2006;67:944–953
- . Interferon-beta inhibits mitogen induced astrocyte proliferation in vitro. J. Neuroimmunol. 1998;86:155–162
- . Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 1980;85:890–902
- . Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation. Biochem. Pharmacol. 2000;60:979–988
- . Astrocytes stimulate interleukin-17 and interferon-γ production in vitro. J. Neurosci. Res. 2007;85:3598–3606
- . Astrocytes in multiple sclerosis: a product of their environment. Cell. Mol. Life Sci. 2008;65:2702–2720
- . Differing effects of IFN beta vs. IFN gamma in MS: gene expression in cultured astrocytes. Neurology. 2001;57:681–685
- . Counteracting effect of IFN-beta on IFN-gamma-induced proliferation of human astrocytes in culture. Mult. Scler. 1996;1:279–287
- . Pretreatment of astrocytes with interferon-alpha/beta impairs interferon-gamma induction of nitric oxide synthase. J. Neurochem. 1997;68:2547–2551
- . Pretreatment of astrocytes with interferon-alpha/beta prevents neuronal mitochondrial respiratory chain damage. J. Neurochem. 1998;70:432–434
- . Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells. J. Cell Biol. 1986;102:2244–2253
- . New natural history of interferon-beta-treated relapsing multiple sclerosis. Ann. Neurol. 2007;61:300–306
- . Proteomic map of peripheral blood mononuclear cells. Proteomics. 2008;8:2045–2051
- . Biomechanical and proteomic analysis of INF-beta-treated astrocytes. Nanotechnology. 2009;20:455106
- . MHC I upregulation influences astroglial reaction and synaptic plasticity in the spinal cord after sciatic nerve transaction. Exp. Neurol. 2006;200:521–531
PII: S0165-5728(10)00007-X
doi: 10.1016/j.jneuroim.2010.01.002
© 2010 Elsevier B.V. All rights reserved.
« Previous
Next »
Journal of Neuroimmunology
Volume 221, Issue 1
, Pages 115-120
, 15 April 2010
